Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.62B | $10.80B | $3.07B | $2.98B | $2.27B | $3.67B | $3.88B | $3.57B |
| Cost of revenue | $7.71B | $8.69B | $2.64B | $2.58B | $1.94B | $2.69B | $3.02B | $3.20B |
| Gross profit | $907.0M | $2.10B | $428.7M | $401.3M | $329.8M | $987.0M | $864.3M | $364.5M |
| Gross margin | 10.5% | 19.5% | 14.0% | 13.5% | 14.5% | 26.9% | 22.3% | 10.2% |
| R&D | $124.2M | $132.8M | $64.5M | $70.2M | $0 | $0 | $0 | $0 |
| Operating income | −$646.5M | $465.0M | −$441.2M | −$672.5M | −$352.8M | −$88.0M | $430.1M | −$21.9M |
| EBITDA | $170.9M | $1.27B | $339.7M | −$344.5M | −$145.5M | $163.4M | $642.6M | $182.6M |
| Net income | $101.4M | $716.2M | −$160.4M | −$678.1M | −$446.7M | $1.36B | $666.3M | $174.6M |
| Net margin | 1.2% | 6.6% | -5.2% | -22.8% | -19.7% | 36.9% | 17.2% | 4.9% |
| EPS (diluted) | 0.15 | 1.07 | -0.24 | -1.01 | -0.67 | 2.03 | 1.00 | 0.26 |
Annual figures · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| ARGVXAmerican Century One Choice 2060 Portfolio;Investor | $17.50 | +0.40% | $447M | — |
| AOVIXAmerican Century Investments One Choice Portfolio: Very Aggressive Investor Class | $23.08 | +0.52% | $369M | — |
| EXHAXManning & Napier Fd, Inc. Pro-Blend Maximum Term Srs Cl S | $25.99 | +0.74% | $418M | — |
| FSCHXFidelity Select Chemical Pt | $14.43 | +1.33% | $438M | — |
| GTLIXGlenmede Quantitative U.S. Large Cap Core Equity Portfolio |
No one on the platform currently holds ARGVX.
No tracked institution reports a position in ARGVX as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-12-19 | $1.7273 | 2025-12-19 |
| 2024-12-20 | $0.4967 | 2024-12-20 |
| 2023-12-21 | $0.2301 | 2023-12-21 |
No one on the platform has traded ARGVX yet.
| $24.08 |
| +0.84% |
| $437M |
| — |
| LEAOXLazard Emerging Markets Equity Advantage Portfolio Open Shares | $19.84 | +1.07% | $465M | — |
| OCMPXLazard International Quality Growth Portfolio Open Shares | $16.33 | +0.49% | $374M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.